Sources | Names Used |
---|---|
CTRPv2 | navitoclax:MST-312 (1:1 mol/mol) |
PharmacoGx | navitoclax:MST-312 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSWIM5 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | ZSWIM4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | ZSCAN20 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | ZSCAN18 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ZSCAN12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNHIT2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | ZNF93 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |